la renon healthcare's journey began in 2007 with the chronic therapeutic segment of nephrology. we were the first company to foray into this domain with a focus on early stage chronic kidney disease (ckd) patients. it was a daunting task to begin with especially in a country like india, where at least 6 crore individuals have been suspected to be suffering from some form of kidney disease and of which only 1% (6-7 lakhs) are being diagnosed or might be under some form of renal therapy. however, within a short span of time, la renon has established itself as a leader in the field of nephrology and serves the highest number of chronic kidney disease (ckd) patients in india today.
排列3走势图南方双彩网recombinant human erythropoietin alfa injection 2000 iu, 4000iu,6000 iu & 10000 iu
preservative free heparin sodium for injection 1000 iu/ml (5ml/amp)
levocarnitine inj. 200 mg / ml (5 ml amp)
tri sodium citrate catheter locking solution 46.7%